Screener
Arcus Biosciences RCUS Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's return on invested capital?
- Arcus Biosciences (RCUS) reported return on invested capital of -116% in Q2 2026.
- How has Arcus Biosciences's return on invested capital changed year-over-year?
- Arcus Biosciences's return on invested capital decreased by 54.4% year-over-year, from -75.1% to -116%.
- What is the long-term trend for Arcus Biosciences's return on invested capital?
- Over 4 years (2021 to 2025), Arcus Biosciences's return on invested capital has grown at a 67.0% compound annual growth rate (CAGR), from 9% to -70.1%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Arcus Biosciences's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude